PACIFIC: A double-blind, placebo-controlled phase III study of durvalumab after chemoradiation therapy in patients with stage III, locally advanced, unresectable NSCLC

Laack, H. -E. and Schulz, C. and Wolff, T. and Rueckert, A. and Reck, M. and Faehling, M. and Fischer, J. R. and de Wit, M. (2018) PACIFIC: A double-blind, placebo-controlled phase III study of durvalumab after chemoradiation therapy in patients with stage III, locally advanced, unresectable NSCLC. ONCOLOGY RESEARCH AND TREATMENT, 41 (Suppl1). pp. 186-187. ISSN 2296-5270, 2296-5262

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin II
Depositing User: Petra Gürster
Date Deposited: 23 Jun 2020 12:53
Last Modified: 23 Jun 2020 12:53
URI: https://pred.uni-regensburg.de/id/eprint/15434

Actions (login required)

View Item View Item